Literature DB >> 15827062

Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.

Olivier Fondard1, Delphine Detaint, Bernard Iung, Christine Choqueux, Homa Adle-Biassette, Mohamed Jarraya, Ulrich Hvass, Jean-Paul Couetil, Dominique Henin, Jean-Baptiste Michel, Alec Vahanian, Marie-Paule Jacob.   

Abstract

AIMS: Aortic valve diseases are characterized by pathological remodelling of valvular tissue but the cellular and molecular effectors involved in these processes are not well known. The role of matrix metalloproteinase (MMP)-2, MMP-9, MMP-3, MMP-7, and tissue inhibitor of matrix metalloproteinase (TIMP)-1 and TIMP-2 are investigated here. METHODS AND
RESULTS: Histological analysis of pathological valves [aortic stenosis (AS) (n=49), aortic regurgitation (AR) (n=23)] and control valves (n=8) was performed. The main tissue abnormalities (calcification, inflammatory cells, and capillaries) observed in AS were less severe or absent in AR. However, both groups of pathological valves displayed similar histological signs of extracellular matrix (ECM) remodelling. Biochemical analysis of MMPs and TIMPs (gelatin and casein zymography and ELISA) was performed on valve extracts. MMP-2 activity was not significantly different in control and pathological valves. Increases in MMP-9 and MMP-3 in AS demonstrated an inflammatory state. Finally, there was a four- to seven-fold increase of TIMP-1 in pathological valves. TIMP-1, TIMP-2, and MMP-2 were synthesized by the valvular interstitial cells in primary culture.
CONCLUSION: This study demonstrates the involvement of the MMP/TIMP system in ECM remodelling of both AS and AR. These findings provide evidence of inflammatory injury more severe in AS than in AR and involvement of mesenchymal cell response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827062     DOI: 10.1093/eurheartj/ehi248

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  72 in total

1.  Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients.

Authors:  Kana Wakabayashi; Takeshi Tsujino; Yoshiro Naito; Akira Ezumi; Masaaki Lee-Kawabata; Shinji Nakao; Akiko Goda; Yasushi Sakata; Kazuhiro Yamamoto; Takashi Daimon; Tohru Masuyama
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

Review 2.  The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology.

Authors:  Amber C Liu; Vineet R Joag; Avrum I Gotlieb
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

Review 3.  Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models.

Authors:  Robert M Weiss; Jordan D Miller; Donald D Heistad
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

4.  Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.

Authors:  Jae-Joon Jung; Mahmoud Razavian; Azariyas A Challa; Lei Nie; Reza Golestani; Jiasheng Zhang; Yunpeng Ye; Kerry S Russell; Simon P Robinson; Donald D Heistad; Mehran M Sadeghi
Journal:  J Nucl Med       Date:  2015-04-23       Impact factor: 10.057

5.  Molecular and functional characteristics of heart-valve interstitial cells.

Authors:  Adrian H Chester; Patricia M Taylor
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

Review 6.  How to make a heart valve: from embryonic development to bioengineering of living valve substitutes.

Authors:  Donal MacGrogan; Guillermo Luxán; Anita Driessen-Mol; Carlijn Bouten; Frank Baaijens; José Luis de la Pompa
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

7.  The stretch responsive microRNA miR-148a-3p is a novel repressor of IKBKB, NF-κB signaling, and inflammatory gene expression in human aortic valve cells.

Authors:  Vishal Patel; Katrina Carrion; Andrew Hollands; Andrew Hinton; Thomas Gallegos; Jeffrey Dyo; Roman Sasik; Emma Leire; Gary Hardiman; Salah A Mohamed; Sanjay Nigam; Charles C King; Victor Nizet; Vishal Nigam
Journal:  FASEB J       Date:  2015-01-28       Impact factor: 5.191

Review 8.  Heart Valve Biomechanics and Underlying Mechanobiology.

Authors:  Salma Ayoub; Giovanni Ferrari; Robert C Gorman; Joseph H Gorman; Frederick J Schoen; Michael S Sacks
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

Review 9.  Cell-matrix mechanics and pattern formation in inflammatory cardiovascular calcification.

Authors:  Jeffrey J Hsu; Jina Lim; Yin Tintut; Linda L Demer
Journal:  Heart       Date:  2016-07-12       Impact factor: 5.994

10.  Histopathological study of congenital aortic valve malformations in 32 children.

Authors:  Ping Huang; Hongwei Wang; Yanping Li; Peixuan Cheng; Qingjun Liu; Zhenlu Zhang; Jianying Liu
Journal:  Front Med China       Date:  2007-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.